EBR/IBAB (EBR/IBAB)

Euronext Brussels: EBR/IBAB · EUR

€16.5

+0.16 (+1.0%)· Recorded snapshot

Market cap	480M
Revenue (ttm)	639M
Net income (ttm)	24.6M
EPS (ttm)	€0.80
Shares out	29.1M
P/E (trailing)	20.7x
P/E (forward)	20.2x
Dividend	€0.25 (1.51%)
Volume	1,376
Beta	1.26

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 639M
Net income (ttm): 24.6M
EPS (ttm): €0.80
P/E (trailing): 20.7x
P/E (forward): 20.2x
Market cap: 480M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E20.2

P25 n/aP50 n/aP75 n/a

Trailing P/E20.7

P25 n/aP50 n/aP75 n/a

ROE20.7

P25 n/aP50 n/aP75 n/a

ROIC17.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All EBR/IBAB indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

EUR

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Belgium
Country code	BE
Earnings date	2026-11-26
Employees	2,264
Employees change	134
Employees growth	6.29%
Enterprise value	EUR 554.9M
Exchange	Euronext Brussels
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1986
Industry	Medical Devices
Is primary listing	Yes
ISIN number	BE0003766806
Last earnings date	2026-08-27
Last refreshed	2026-10-29
Last stock split date	1999-06-11
Last stock split type	Forward
Market cap	EUR 480M
Next earnings date	2026-11-26
Price	EUR 16.50
Price currency	EUR
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-29
Symbol	ebr/IBAB
Website	https://www.iba-worldwide.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	62.32x
Average P/E ratio (3Y)	29.69x
Average P/E ratio (5Y)	52.51x
Earnings yield	4.84%
EV/Earnings	22.36x
EV/EBIT	12.91x
EV/EBITDA	9.79x
EV/Sales	0.86x
FCF / EV yield	-0.51%
FCF yield	-0.59%
Forward P/E	20.24x
Graham number	8.53891
Graham upside	-47.74%
Lynch fair value	EUR 4.00
Lynch upside	-75.55%
P/B ratio	3.99x
P/E ratio	20.65x
P/OCF ratio	104.49x
P/S ratio	0.74x
Price / tangible book value	6.27x
Price/EBITDA ratio	10.18x
Sector forward P/E	22.86x
Sector P/E	29.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	6.35%
EBITDA margin	7.3%
Effective tax rate	17.56%
Gross margin	34.2%
Operating margin	6.35%
Pretax margin	4.67%
Profit margin	3.85%
Profit per employee	EUR 10,871
Profitable quarters	2
Profitable years	2
Revenue per employee	EUR 282,244
ROA	3.67%
ROA (5Y)	1.92%
ROCE	18.72%
ROE	20.66%
ROE (5Y)	3.78%
ROIC	17.23%
Tax / revenue	0.82%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	38.87%
EPS growth 10Y	-8.22%
EPS growth 5Y	-10.83%
EPS growth quarters	1
EPS growth years	2
Gross profit growth	16.07%
Gross profit growth (Q)	21.02%
Gross profit growth 3Y	26.01%
Gross profit growth 5Y	8.37%
Net income growth	44.75%
Net income growth (QoQ)	-39.16%
Net income growth 5Y	-10.15%
Net income growth quarters	1
Net income growth years	2
OCF growth	63.4%
OCF growth 10Y	-11.2%
OCF growth 5Y	-44.58%
Operating income growth	6.5%
Operating income growth (Q)	83.06%
Operating income growth 5Y	-4.95%
Revenue growth	7.1%
Revenue growth (Q)	6.17%
Revenue growth (QoQ)	2.69%
Revenue growth 10Y	8.05%
Revenue growth 3Y	19.91%
Revenue growth 5Y	13.49%
Revenue growth quarters	9
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -7.4M
Depreciation and amortization	EUR 6.1M
EBIT	EUR 40.6M
EBITDA	EUR 46.7M
EPS	EUR 0.80
FCF per share	EUR -0.10
Financing cash flow	EUR 34.8M
Free cash flow	EUR -2.8M
Gross profit	EUR 218.5M
Income taxes	EUR 5.2M
Investing cash flow	EUR -30.1M
Net borrowing	EUR 43.3M
Net cash flow	EUR 6.9M
Net income	EUR 24.6M
Operating income	EUR 40.6M
Revenue	EUR 639M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.46
Book value per share	EUR 4.06
Debt / EBITDA	2.19
Debt / equity	1
Interest coverage	17.76
Long-term assets	EUR 223.3M
Long-term liabilities	EUR 97.6M
Net cash (debt)	EUR -75M
Net cash / market cap	-15.77%
Net debt / EBITDA	1.61
Net debt / equity	0.63
Piotroski F-Score	5
Property, plant and equipment	EUR 60.4M
Shareholders' equity	EUR 119.2M
Tangible book value	EUR 75.8M
Tangible book value per share	EUR 2.58
Total assets	EUR 753.9M
Total cash	EUR 43.8M
Total debt	EUR 118.8M
Total liabilities	EUR 634.7M
WACC	9.27%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.93
Current assets	EUR 530.6M
Current liabilities	EUR 537.1M
Current ratio	0.99
Inventory turnover	2.66
Net working capital	EUR -13.4M
Quick ratio	0.58
Working capital	EUR -6.5M
Working capital turnover	-34.7

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-4.23%
Dividend growth	4.17%
Dividend growth (10Y)	-15.77%
Dividend growth (3Y)	5.98%
Dividend growth (5Y)	4.56%
Dividend growth years	1
Dividend payment date	2026-07-01
Dividend payment years	7
Dividend payout frequency	Annual
Dividend per share	EUR 0.25
Dividend yield	1.52%
Ex-dividend date	2026-06-15
Last dividend	EUR 0.25
Payout ratio	28.68%
Shareholder yield	-2.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-61.69%
10Y return CAGR	-8.51%
10Y total return	-58.89%
150-day SMA	EUR 15.61
15Y price change	193.59%
15Y return CAGR	8.19%
15Y total return	225.51%
1D price change	0.98%
1M price change	5.63%
1M total return	5.63%
1W price change	4.17%
1W total return	4.17%
1Y price change	49.46%
1Y return CAGR	51.06%
1Y total return	51.02%
20-day SMA	EUR 15.97
200-day SMA	EUR 15.42
20Y price change	23.78%
20Y return CAGR	1.76%
20Y total return	41.73%
3M price change	2.48%
3M total return	2.48%
3Y price change	83.54%
3Y return CAGR	23.79%
3Y total return	89.73%
50-day SMA	EUR 15.76
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 17.76
52-week high date	2026-07-02
52-week low	EUR 9.90
52-week low date	2025-11-19
5Y price change	-2.71%
5Y return CAGR	0.48%
5Y total return	2.4%
6M price change	21.68%
6M total return	22.96%
All-time high	EUR 65.90
All-time high date	1999-05-03
All-time low	EUR 2.60
All-time low date	2003-03-28
Average true range (ATR)	EUR 0.42
Average volume	15.1K
Beta (1Y)	0.9
Beta (2Y)	0.85
Beta (5Y)	1.26
Change from 52-week high	-7.09%
Change from 52-week low	66.67%
Change from all-time high	-74.96%
Change from all-time low	534.62%
Change from open	1.85%
Day's gap	-0.86%
Dollar volume	EUR 22,704
High price	EUR 16.60
Low price	EUR 16.20
Monthly RSI	59.33
Open price	EUR 16.20
Position in 52-week range	75%
Previous close	EUR 16.34
Price vs 150-day SMA	5.69%
Price vs 20-day SMA	3.33%
Price vs 200-day SMA	7.02%
Price vs 50-day SMA	4.72%
Relative volume	0.09
RSI	62.26
Sharpe ratio	1.41
Sharpe ratio (3Y)	0.58
Sharpe ratio (5Y)	0.17
Sortino ratio	2.61
Sortino ratio (3Y)	1.11
Sortino ratio (5Y)	0.44
Volume	1.4K
Weekly RSI	56.02
YTD price change	27.71%
YTD total return	29.05%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25.9M
Shares change (YoY)	4.23%
Shares held by institutions	14.03%
Shares outstanding	29.1M

Deeper analysis on EBR/IBAB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this EBR/IBAB report

Is a complete EBR/IBAB research report available?

No complete published report is available for ebr/IBAB (EBR/IBAB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

EBR/IBAB (EBR/IBAB)

Price

Financial snapshot

Fair-value bridge

Latest news · EBR/IBAB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBR/IBAB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EBR/IBAB

Frequently asked questions